...
首页> 外文期刊>Stem cells international >Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
【24h】

Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma

机译:癌症干细胞标志物联结(CD105)诱导上皮间充质转换(EMT)但在透明细胞肾细胞癌中没有转移

获取原文
           

摘要

Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of kidney cancer. We previously reported that CD105(+) subpopulation in human ccRCC tumors possesses tumor cell self-renewal and chemoresistance capability. In this study, we showed that CD105(+) ACHN tumor cells exhibit epithelial mesenchymal transition (EMT) phenotype with high expression of mesenchymal marker N-cadherin and low expression of epithelial marker E-cadherin. They are more motile and invasive compared to the unselected parental ACHN tumor cells. The knockdown of CD105 by RNA interference led to the downregulation of N-cadherin and the upregulation of E-cadherin and reduced motility and invasiveness of CD105(+) cells. Overexpression of stem cell factor MYC in CD105 knocked down cells increased mesenchymal markers and cell motility. However, the CD105(+) population of tumor cells does not exhibit an increase metastatic potential in vivo. Findings from this study support that CD105 plays a functional role in maintaining cancer stem cell and EMT phenotype, with MYC as a common mediator for both of these traits. Our work suggests that the ability to metastasize does not coincide with the cancer stem cell or EMT function of CD105.
机译:透明细胞肾细胞癌(CCRCC)是肾癌最常见的组织学亚型。我们之前报道的是,人类CCRCC肿瘤的CD105(+)亚群具有肿瘤细胞自我更新和化学血容量能力。在这项研究中,我们表明CD105(+)ACHN肿瘤细胞表现出上皮间充质转变(EMT)表型,具有高表达的间充质标记物N-钙粘蛋白和上皮标记物E-Cadherin的低表达。与未选择的父母Achn肿瘤细胞相比,它们更具动机和侵袭性。通过RNA干扰的CD105敲低导致N-Cadherin的下调和e-cadherin的上调和CD105(+)细胞的运动性和侵袭性降低。干细胞因子MyC在CD105中的过度表达撞击细胞增加的间充质标志物和细胞运动性。然而,CD105(+)肿瘤细胞的群体不会在体内提高转移性​​潜力。从该研究支持的结果支持CD105在维持癌症干细胞和EMT表型中起作用的作用,用Myc作为这些性状的常见介体。我们的作品表明,转移的能力与CD105的癌症干细胞或EMT功能不一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号